These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

533 related articles for article (PubMed ID: 17601629)

  • 41. Drug nanocrystals in the commercial pharmaceutical development process.
    Möschwitzer JP
    Int J Pharm; 2013 Aug; 453(1):142-56. PubMed ID: 23000841
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nanotechnology versus other techniques in improving drug dissolution.
    Kwok PC; Chan HK
    Curr Pharm Des; 2014; 20(3):474-82. PubMed ID: 23651399
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nanoparticulate strategies for effective delivery of poorly soluble therapeutics.
    Gokce EH; Ozyazici M; Souto EB
    Ther Deliv; 2010 Jul; 1(1):149-67. PubMed ID: 22816125
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recent advancements in mechanical reduction methods: particulate systems.
    Leleux J; Williams RO
    Drug Dev Ind Pharm; 2014 Mar; 40(3):289-300. PubMed ID: 23988193
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preparation, characterization and in vivo evaluation of amorphous atorvastatin calcium nanoparticles using supercritical antisolvent (SAS) process.
    Kim MS; Jin SJ; Kim JS; Park HJ; Song HS; Neubert RH; Hwang SJ
    Eur J Pharm Biopharm; 2008 Jun; 69(2):454-65. PubMed ID: 18359211
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dosage form design and development.
    Allen LV
    Clin Ther; 2008 Nov; 30(11):2102-11. PubMed ID: 19108798
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Towards improved therapies using nanopharmaceuticals: recent patents on pharmaceutical nanoformulations.
    Horstkotte E; Odoerfer KI
    Recent Pat Food Nutr Agric; 2012 Dec; 4(3):220-44. PubMed ID: 23013408
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Real-time electrochemical monitoring of drug release from therapeutic nanoparticles.
    Mora L; Chumbimuni-Torres KY; Clawson C; Hernandez L; Zhang L; Wang J
    J Control Release; 2009 Nov; 140(1):69-73. PubMed ID: 19679152
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Strategies at the interface of drug discovery and development: early optimization of the solid state phase and preclinical toxicology formulation for potential drug candidates.
    Palucki M; Higgins JD; Kwong E; Templeton AC
    J Med Chem; 2010 Aug; 53(16):5897-905. PubMed ID: 20527889
    [No Abstract]   [Full Text] [Related]  

  • 50. A new approach in the prediction of the dissolution behavior of suspended particles by means of their particle size distribution.
    Tinke AP; Vanhoutte K; De Maesschalck R; Verheyen S; De Winter H
    J Pharm Biomed Anal; 2005 Oct; 39(5):900-7. PubMed ID: 16023816
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Design and evaluation of itraconazole loaded solid lipid nanoparticulate system for improving the antifungal therapy.
    Mukherjee S; Ray S; Thakur RS
    Pak J Pharm Sci; 2009 Apr; 22(2):131-8. PubMed ID: 19339221
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Advanced screening assays to rapidly identify solubility-enhancing formulations: high-throughput, miniaturization and automation.
    Dai WG; Pollock-Dove C; Dong LC; Li S
    Adv Drug Deliv Rev; 2008 Mar; 60(6):657-72. PubMed ID: 18222563
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A comparative study of top-down and bottom-up approaches for the preparation of micro/nanosuspensions.
    Verma S; Gokhale R; Burgess DJ
    Int J Pharm; 2009 Oct; 380(1-2):216-22. PubMed ID: 19596059
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nanoparticles for drug delivery: the need for precision in reporting particle size parameters.
    Gaumet M; Vargas A; Gurny R; Delie F
    Eur J Pharm Biopharm; 2008 May; 69(1):1-9. PubMed ID: 17826969
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of nanotechnology in pharmaceutical product development.
    Devalapally H; Chakilam A; Amiji MM
    J Pharm Sci; 2007 Oct; 96(10):2547-65. PubMed ID: 17688284
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Formulation and pharmacokinetics of lipid nanoparticles of a chemically sensitive nitrogen mustard derivative: Chlorambucil.
    Sharma P; Ganta S; Denny WA; Garg S
    Int J Pharm; 2009 Feb; 367(1-2):187-94. PubMed ID: 18930127
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nano- and micro-particulate formulations of poorly water-soluble drugs by using a novel optimized technique.
    Douroumis D; Fahr A
    Eur J Pharm Biopharm; 2006 Jun; 63(2):173-5. PubMed ID: 16621482
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Polysaccharide-decorated nanoparticles.
    Lemarchand C; Gref R; Couvreur P
    Eur J Pharm Biopharm; 2004 Sep; 58(2):327-41. PubMed ID: 15296959
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of single pot and multiphase granulation. Part 1: Effect of the high shear granulator on granule properties according to the drug substance and its concentration.
    Giry K; Viana M; Genty M; Louvet F; Wüthrich P; Chulia D
    Pharm Dev Technol; 2009; 14(2):138-48. PubMed ID: 19519186
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Preparation and evaluation of self-microemulsifying drug delivery system containing vinpocetine.
    Cui SX; Nie SF; Li L; Wang CG; Pan WS; Sun JP
    Drug Dev Ind Pharm; 2009 May; 35(5):603-11. PubMed ID: 19040178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.